A 1, 8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replication S Massari, D Daelemans, ML Barreca, A Knezevich, S Sabatini, ... Journal of medicinal chemistry 53 (2), 641-648, 2010 | 158 | 2010 |
A broad anti-influenza hybrid small molecule that potently disrupts the interaction of polymerase acidic protein–basic protein 1 (PA-PB1) subunits S Massari, G Nannetti, J Desantis, G Muratore, S Sabatini, G Manfroni, ... Journal of Medicinal Chemistry 58 (9), 3830-3842, 2015 | 99 | 2015 |
Structure− activity relationship study on anti-HIV 6-desfluoroquinolones O Tabarrini, S Massari, D Daelemans, M Stevens, G Manfroni, S Sabatini, ... Journal of medicinal chemistry 51 (17), 5454-5458, 2008 | 87 | 2008 |
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors A Astolfi, T Felicetti, N Iraci, G Manfroni, S Massari, D Pietrella, O Tabarrini, ... Journal of medicinal chemistry 60 (4), 1598-1604, 2017 | 66 | 2017 |
Inhibition of subgenomic hepatitis C virus RNA replication by acridone derivatives: identification of an NS3 helicase inhibitor G Manfroni, J Paeshuyse, S Massari, S Zanoli, B Gatto, G Maga, ... Journal of medicinal chemistry 52 (10), 3354-3365, 2009 | 64 | 2009 |
Studies on anti-HIV quinolones: new insights on the C-6 position S Massari, D Daelemans, G Manfroni, S Sabatini, O Tabarrini, ... Bioorganic & medicinal chemistry 17 (2), 667-674, 2009 | 64 | 2009 |
Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly S Massari, G Nannetti, L Goracci, L Sancineto, G Muratore, S Sabatini, ... Journal of Medicinal Chemistry 56 (24), 10118-10131, 2013 | 60 | 2013 |
Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to … S Sabatini, F Gosetto, N Iraci, ML Barreca, S Massari, L Sancineto, ... Journal of medicinal chemistry 56 (12), 4975-4989, 2013 | 56 | 2013 |
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase G Manfroni, F Meschini, ML Barreca, P Leyssen, A Samuele, N Iraci, ... Bioorganic & medicinal chemistry 20 (2), 866-876, 2012 | 53 | 2012 |
Polymerase acidic protein–basic protein 1 (PA–PB1) protein–protein interaction as a target for next-generation anti-influenza therapeutics S Massari, L Goracci, J Desantis, O Tabarrini Journal of medicinal chemistry 59 (17), 7699-7718, 2016 | 52 | 2016 |
Engagement of nuclear coactivator 7 by 3-hydroxyanthranilic acid enhances activation of aryl hydrocarbon receptor in immunoregulatory dendritic cells M Gargaro, C Vacca, S Massari, G Scalisi, G Manni, G Mondanelli, ... Frontiers in Immunology 10, 1973, 2019 | 50 | 2019 |
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction T Felicetti, R Cannalire, D Pietrella, G Latacz, A Lubelska, G Manfroni, ... Journal of medicinal chemistry 61 (17), 7827-7848, 2018 | 47 | 2018 |
Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity J Desantis, G Nannetti, S Massari, ML Barreca, G Manfroni, V Cecchetti, ... European Journal of Medicinal Chemistry 138, 128-139, 2017 | 45 | 2017 |
From 6-Aminoquinolone Antibacterials to 6-Amino-7-thiopyranopyridinylquinolone Ethyl Esters as Inhibitors of Staphylococcus aureus Multidrug Efflux Pumps M Pieroni, M Dimovska, JP Brincat, S Sabatini, E Carosati, S Massari, ... Journal of medicinal chemistry 53 (11), 4466-4480, 2010 | 43 | 2010 |
Computer‐Aided Design, Synthesis and Validation of 2‐Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti‐HIV‐1 Tat‐Mediated Transcription Activity L Sancineto, N Iraci, S Massari, V Attanasio, G Corazza, ML Barreca, ... ChemMedChem 8 (12), 1941-1953, 2013 | 40 | 2013 |
Structural Investigation of the Naphthyridone Scaffold: Identification of a 1, 6‐Naphthyridone Derivative with Potent and Selective Anti‐HIV Activity O Tabarrini, S Massari, L Sancineto, D Daelemans, S Sabatini, ... ChemMedChem 6 (7), 1249-1257, 2011 | 39 | 2011 |
Blocking HIV-1 replication by targeting the Tat-hijacked transcriptional machinery S Massari, S Sabatini, O Tabarrini Current pharmaceutical design 19 (10), 1860-1879, 2013 | 38 | 2013 |
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3‐Phenyl‐1,4‐benzothiazine Analogues T Felicetti, R Cannalire, MS Burali, S Massari, G Manfroni, ML Barreca, ... ChemMedChem 12 (16), 1293-1302, 2017 | 34 | 2017 |
Functionalized 2, 1-benzothiazine 2, 2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase R Cannalire, D Tarantino, A Astolfi, ML Barreca, S Sabatini, S Massari, ... European journal of medicinal chemistry 143, 1667-1676, 2018 | 32 | 2018 |
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium R Cannalire, D Machado, T Felicetti, SS Costa, S Massari, G Manfroni, ... European Journal of Medicinal Chemistry 140, 321-330, 2017 | 31 | 2017 |